Atea Pharmaceuticals, Inc.

Direct answer

Atea Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker AVIR.

Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to the discovery, development, and commercialization of antiviral treatments for patients with viral infections. Its primary investigational drug, AT-527, is an antiviral currently undergoing Phase II clinical trials for the treatment of COVID-19. Beyond its lead candidate, Atea's development pipeline encompasses a range of other drug...

Can you invest in Atea Pharmaceuticals, Inc.?

Yes. Atea Pharmaceuticals, Inc. trades publicly on NASDAQ as AVIR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Atea Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.